Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Drazner

Showing results (21-30 of 290) with videos related to

Pageof 29
Sort By:
JAMA|July 19, 2022
Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection FractionMark H Drazner
Hypertension (Dallas, Tex. : 1979)|May 5, 2004
Left ventricular hypertrophy is more common in black than white hypertensives: is this news?Mark H Drazner
Journal of Cardiac Failure|May 15, 2025
HFSA Membership - Join A Community of "Your People"Mark H Drazner
JACC. Cardiovascular Imaging|January 19, 2013
Is the inferior vena cava really superior?Mark H Drazner
The New England Journal of Medicine|July 3, 2009
Racial differences in heart failureMark H Drazner
JAMA|September 27, 2022
Left Ventricular Assist Devices in Advanced Heart FailureMark H Drazner
Journal of Cardiac Failure|February 12, 2022
Treating Patients with Heart Failure and Mild Symptoms: Stay Awake at the WheelMark H Drazner
Journal of Cardiac Failure|April 14, 2022
Implementation of the 2022 ACC/AHA/HFSA Heart Failure Guideline: A Call to ActionMark H Drazner
The New England Journal of Medicine|August 27, 2021
SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable FoeMark H Drazner
Current Opinion in Cardiology|May 12, 2016
Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failureSonia Garg, Mark H Drazner
Pageof 29

Showing results (21-30 of 290) with videos related to

Sort By:
Pageof 29
JAMA|July 19, 2022
Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection FractionMark H Drazner
Hypertension (Dallas, Tex. : 1979)|May 5, 2004
Left ventricular hypertrophy is more common in black than white hypertensives: is this news?Mark H Drazner
Journal of Cardiac Failure|May 15, 2025
HFSA Membership - Join A Community of "Your People"Mark H Drazner
JACC. Cardiovascular Imaging|January 19, 2013
Is the inferior vena cava really superior?Mark H Drazner
The New England Journal of Medicine|July 3, 2009
Racial differences in heart failureMark H Drazner
JAMA|September 27, 2022
Left Ventricular Assist Devices in Advanced Heart FailureMark H Drazner
Journal of Cardiac Failure|February 12, 2022
Treating Patients with Heart Failure and Mild Symptoms: Stay Awake at the WheelMark H Drazner
Journal of Cardiac Failure|April 14, 2022
Implementation of the 2022 ACC/AHA/HFSA Heart Failure Guideline: A Call to ActionMark H Drazner
The New England Journal of Medicine|August 27, 2021
SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable FoeMark H Drazner
Current Opinion in Cardiology|May 12, 2016
Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failureSonia Garg, Mark H Drazner
Pageof 29